Reimbursement for Breast-Cancer Risk Test to Be Cut

The price of a popular genetic test that predicts women's risk of breast cancer is likely to drop after the rate cut goes into effect Jan. 1.



from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304361604579288591617575358.html?mod=pls_whats_news_us_business_f

via IFTTT